These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2497073)

  • 1. Urokinase-type plasminogen activator biosynthesis is induced by the EJ-Ha-ras oncogene in CL26 mouse colon carcinoma cells.
    Testa JE; Medcalf RL; Cajot JF; Schleuning WD; Sordat B
    Int J Cancer; 1989 May; 43(5):816-22. PubMed ID: 2497073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.
    Sappino AP; Huarte J; Belin D; Vassalli JD
    J Cell Biol; 1989 Nov; 109(5):2471-9. PubMed ID: 2509486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface.
    Huarte J; Belin D; Bosco D; Sappino AP; Vassalli JD
    J Cell Biol; 1987 May; 104(5):1281-9. PubMed ID: 3106363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene.
    Brunner G; Pohl J; Erkell LJ; Radler-Pohl A; Schirrmacher V
    J Cancer Res Clin Oncol; 1989; 115(2):139-44. PubMed ID: 2654132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced plasminogen activator production of Syrian hamster embryo cells transformed by chemicals or the c-Ha-ras oncogene: type of plasminogen activators involved and their contribution to the transformed phenotype.
    de Kok AJ; Sips H; Chang GT; Verheijen JH
    Carcinogenesis; 1989 Jul; 10(7):1155-61. PubMed ID: 2500266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
    Niedbala MJ; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression.
    Botteri FM; Ballmer-Hofer K; Rajput B; Nagamine Y
    J Biol Chem; 1990 Aug; 265(22):13327-34. PubMed ID: 1695907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells.
    Rondeau E; Guidet B; Lacave R; Bens M; Sraer J; Nagamine Y; Ardaillou R; Sraer JD
    Biochim Biophys Acta; 1990 Nov; 1055(2):165-72. PubMed ID: 2122915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid.
    Vitti G; Hamilton JA
    Arthritis Rheum; 1988 Aug; 31(8):1046-51. PubMed ID: 3136776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenicity of EJ-ras oncogene transformed NIH 3T3 cells and expression of plasminogen activators.
    Sidhu MK; Russo MS; Zirvi KA; Scala L; Kumar S
    Cell Biol Int Rep; 1990 Jun; 14(6):527-42. PubMed ID: 2164452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of the K-ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis.
    Allgayer H; Wang H; Shirasawa S; Sasazuki T; Boyd D
    Br J Cancer; 1999 Aug; 80(12):1884-91. PubMed ID: 10471035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and secretion of porcine urokinase in Saccharomyces cerevisiae: characterization of the secreted gene product.
    Zaworski PG; Marotti KR; MacKay V; Yip C; Gill GS
    Gene; 1989 Dec; 85(2):545-51. PubMed ID: 2516832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1.
    Davies BR; Davies MP; Gibbs FE; Barraclough R; Rudland PS
    Oncogene; 1993 Apr; 8(4):999-1008. PubMed ID: 8455951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
    Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase secretion from human colon carcinomas induced by endogenous diglycerides.
    Marian B; Harvey S; Infante D; Markus G; Winawer S; Friedman E
    Cancer Res; 1990 Apr; 50(8):2245-50. PubMed ID: 2107972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
    Antalis TM; Reeder JA
    Int J Cancer; 1995 Sep; 62(5):619-26. PubMed ID: 7665235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
    Pepper MS; Belin D; Montesano R; Orci L; Vassalli JD
    J Cell Biol; 1990 Aug; 111(2):743-55. PubMed ID: 1696269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas.
    Sappino AP; Busso N; Belin D; Vassalli JD
    Cancer Res; 1987 Aug; 47(15):4043-6. PubMed ID: 2440556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line.
    Hollas W; Soravia E; Mazar A; Henkin J; Blasi F; Boyd D
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):629-34. PubMed ID: 1322138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.